MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Pro

Is Perrigo's Dermacosmetics Divestiture a Game Changer for Its "Three-S" Strategy

2 days ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Is Target's New Turnaround Strategy a Game Changer

1 months ago

Is American Express's AI Strategy a Game-Changer for Investors

1 week ago

Is Cavvy Energy's Sulfur Strategy a Game Changer for 2026

1 months ago

Is McDonald's New Beverage Strategy a Game Changer for Investors

2 months ago

Coty's perfume business takes another knock with David Beckham fragrance lawsuit

Coty faces a lawsuit from DB Ventures alleging flagrant material breaches of their fragrance license agreement. The legal action targets the management of the David Beckham brand, potentially impactin...

COTY

Stock News•2 days ago

Perrigo Completes Divestiture of Dermacosmetics Business

Perrigo Company completed the sale of its branded Dermacosmetics business to Karo Healthcare for up to €332.6 million. The deal includes €305.6 million in upfront cash, which the company plans to use ...

PRGO

Stock News•5 days ago

Procter & Gamble's Portfolio Strategy: Strengthening Core Brands?

Procter & Gamble is prioritizing an innovation-led strategy to bolster long-term competitive advantage. The company is focusing on core brand growth, successful product launches, and supply chain upgr...

Stock News•5 days ago

Can Oral Ozempic and Label Expansions Revive NVO's Near-Term Growth?

Novo Nordisk is targeting oral Ozempic launches and pediatric label expansions to offset slowing demand and increased competition. These strategic pivots aim to sustain growth as the company faces mou...

NVO